PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
26-Jan-2022 OKYO Pharma Limited - Interim results for the six months to 30 September 2021 OKYO Pharma Limited
26-Jan-2022 Idorsia expands its commercialization partnership with Syneos Health for daridorexant in Europe and Canada Idorsia
26-Jan-2022 Preclinical studies show Aqualung Therapeutic’s eNAMPT- targeting ALT-100 mAb to reduce severity of aggressive prostate cancer Aqualung Therapeutics
26-Jan-2022 Significantly reduced tumor growth with Tumorad® according to new preclinical results Spago Nanomedical AB
26-Jan-2022 InstaDeep Raises $100M to Scale Decision-Making AI Products that Solve Real-World Problems InstaDeep
26-Jan-2022 PharmaLex expands global footprint capabilities for clinical and regulatory services with Phlexglobal merger PharmaLex
26-Jan-2022 FDA Grants Evrysdi® Priority Review Based on Results From Treating Pre-Symptomatic Infants with Spinal Muscular Atrophy PTC Therapeutics, Inc.
26-Jan-2022 People with chronic myeloid leukaemia granted early access to Novartis’ investigational treatment Novartis UK
26-Jan-2022 Biological Discovery Company Launches New Product to Accelerate Target Discovery Synomics
26-Jan-2022 InstaDeep Raises $100M to Scale Decision-Making AI Products that Solve Real-World Problems InstaDeep
26-Jan-2022 HMNC Brain Health Expands International Patent Portfolio with Two Stress-axis Related Substances for Major Depressive Disorder HMNC Brain Health
26-Jan-2022 Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2021 Genmab
26-Jan-2022 Immutep quarterly activities report and Appendix 4C Immutep
26-Jan-2022 First patient dosed in randomised Phase 2 clinical trial of MTL-CEBPA in patients with advanced liver cancer MiNA Therapeutics Limited
26-Jan-2022 Sareum to Participate in the Edison Group’s Global Healthcare “Open House” Virtual Conference (25-27 January 2022) Sareum Holdings plc
26-Jan-2022 ElmediX raises nearly 12 million euros to develop innovative heat technology to fight cancer ElmediX
26-Jan-2022 Cytovation raises $20 million in Series A financing round to advance clinical development of CyPep-1, a first-in-class targeted tumor membrane immunotherapy Cytovation AS
26-Jan-2022 TrakCel and Körber partner to provide orchestration within manufacturing of cell and gene therapies TrakCel
26-Jan-2022 CONFERENCE SERIES WIDENS INVESTOR ACCESS TO CUTTING-EDGE HEALTHCARE STOCKS Edison Group
26-Jan-2022 Scottish bio-tech uFraction8 secures £2.5m commercialisation investment uFraction8